July 19, 2019 / 5:24 AM / 4 months ago

BRIEF-BB Biotech H1 Net Profit At CHF 554 Mln

July 19 (Reuters) - BB BIOTECH AG:

* CONSOLIDATION LEAVES A MARK ON RESULTS IN THE SECOND QUARTER

* Q2 NET ASSET VALUE FELL 9.4% IN CHF AND 8.8% IN EUR, RESULTING IN A SECOND-QUARTER NET LOSS OF CHF 336 MN COMPARED TO A LOSS OF CHF 98 MN IN YEAR-AGO PERIOD

* ANTICIPATES FURTHER PIPELINE PROGRESS

* NET PROFIT FOR PERIOD ENDED JUNE 30, 2019 AMOUNTED TO CHF 554 MN (LOSS OF CHF 70 MN IN H1 2018) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below